Amgen’s rare disease drug Tavneos is under mounting regulatory scrutiny, with the FDA warning of serious liver injuries, ...
The FDA has issued a safety alert for Tavneos, a medication used to treat a rare autoimmune disease, due to recent reports ...
US regulators urge patients to discuss with clinicians the risks of avacopan and to consider an alternative treatment to this medicine, which is approved for a rare autoimmune disease.
The Food and Drug Administration said in its safety alert that a review of studies, documents from avacopan manufacturer ...
A 69-year-old man with hypertension and hyperlipidemia presented to the emergency department with exertional angina. Coronary artery catheterization demonstrated 80% stenosis in the left anterior ...
Urticaria, the second most common drug eruption after exanthematous drug eruptions, 1 is characterized by episodic short-lived swellings of the skin, oropharnyx, or genitalia. Transient leakage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results